tooluniverse-precision-medicine-stratification

Stratifies patients into risk tiers and treatment groups using genomic, clinical, and pharmacogenomic data.

1.7k|254|Updated Mar 3, 2025
One-click install
npx skills add https://github.com/mims-harvard/ToolUniverse --skill tooluniverse-precision-medicine-stratification
Or copy as Structured Prompt for Agent
Please help me install this Agent Skill.
Skill: tooluniverse-precision-medicine-stratification
Source: https://github.com/mims-harvard/ToolUniverse/tree/main/plugins/tooluniverse/skills/tooluniverse-precision-medicine-stratification
Command: npx skills add https://github.com/mims-harvard/ToolUniverse --skill tooluniverse-precision-medicine-stratification

SYSTEM DOCUMENTATION & REQUIREMENTS

What problem does it solve?

Clinicians and researchers need to integrate germline variants, somatic mutations, clinical biomarkers, and pharmacogenomic genotypes into a single actionable patient stratification, but this data lives across dozens of disconnected databases like ClinVar, PharmGKB, GWAS Catalog, and OpenTargets.

Core Features & Use Cases

  • Integrated Risk Scoring: Computes a 0-100 Precision Medicine Risk Score from genetic (0-35), clinical (0-30), molecular (0-25), and pharmacogenomic (0-10) components, mapped to LOW through VERY HIGH tiers.
  • Disease-Specific Pipelines: Routes analysis through dedicated paths for cancer, metabolic, cardiovascular, neurological, rare/monogenic, and autoimmune diseases.
  • Pharmacogenomic Profiling: Evaluates CYP2D6, CYP2C19, SLCO1B1, DPYD, HLA alleles and FDA PGx biomarkers to guide drug selection and dosing.
  • Use Case: Stratify an NSCLC patient with EGFR L858R, TMB 25 mut/Mb, and PD-L1 80% to receive a VERY HIGH risk score, osimertinib as first-line therapy, matched clinical trials, and a monitoring plan.

Quick Start

Ask the agent to stratify a breast cancer patient with a BRCA1 pathogenic variant, ER+/HER2- status, stage IIA, age 45, and request the risk tier and recommended treatment.

Frequently Asked Questions about tooluniverse-precision-medicine-stratification

High-intent search queries and answers about installing and using this skill.

FAQPage Schema
How do I stratify a cancer patient using genomic data?

Provide the disease name plus at least one data layer such as somatic mutations, germline variants, or biomarkers like TMB and PD-L1. The skill resolves the disease to an EFO ID, checks ClinVar and cBioPortal for actionable drivers, and outputs a risk score with treatment recommendations.

What inputs are required for precision medicine stratification?

A disease or condition name and at least one of: germline variants, somatic mutations, gene names, or clinical biomarkers. Optional inputs like age, stage, PGx genotypes, comorbidities, and medications improve scoring accuracy.

How is the precision medicine risk score calculated?

The score sums four components: genetic risk (0-35), clinical risk (0-30), molecular features (0-25), and pharmacogenomic risk (0-10). Totals map to tiers: LOW (0-24), INTERMEDIATE (25-49), HIGH (50-74), and VERY HIGH (75-100).

Which pharmacogenes does the stratification evaluate?

It evaluates CYP2D6, CYP2C19, CYP2C9, SLCO1B1, DPYD, VKORC1, UGT1A1, TPMT, and HLA alleles using PharmGKB clinical annotations, CPIC dosing guidelines, and FDA PGx biomarker labels.

When should I not use patient stratification and use a different analysis?

Use dedicated skills for single variant interpretation, immunotherapy response prediction, drug-drug interaction checks, polygenic risk score calculation, or clinical trial search alone. Stratification is for integrated multi-layer patient assessment.

Does the stratification report include clinical trial matches?

Yes, Phase 8 searches ClinicalTrials.gov for biomarker-driven and precision medicine trials matching the patient's molecular profile, including basket and umbrella trials, with eligibility criteria retrieval.